FDA has been very active over the last year, including issuing and reviewing guidance documents, hosting important DSCSA-related meetings, responding to numerous implementation queries, and issuing a very important proposed rule regarding 3PL and distributor licensure. Hear directly from the agency on recent and upcoming activities and milestones as well as their expectations for the final deadline of November 27, 2023.

The session will highlight how state regulators are preparing for November 2023. This will include how state regulators view product tracing and how assessment of compliance will shift as full implementation of the Drug Supply Chain Security Act approaches.

November 27, 2023, will be here sooner than you can imagine — and the unique challenges of compliance continue. The volume of products, the many successful connections that must be established between trading partners, the intricacies of the law, and the complexities involved with preparing to respond to data and information requests are just some of the top-of-mind implementation issues. A panel of experts will discuss their implementation progress, including key impediments as well as successes, and provide recommendations to other supply chain members as they get ready for full implementation. An opportunity for questions and answers will be provided.